Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience.

Shmueli A, Fraifeld S, Peretz T, Gutfeld O, Gips M, Sosna J, Shaham D.

Value Health. 2013 Sep-Oct;16(6):922-31. doi: 10.1016/j.jval.2013.05.007. Epub 2013 Jul 20.

2.

Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.

Wattson DA, Hunink MG, DiPiro PJ, Das P, Hodgson DC, Mauch PM, Ng AK.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):344-53. doi: 10.1016/j.ijrobp.2014.06.013. Epub 2014 Aug 4.

PMID:
25104066
3.

Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.

Puggina A, Broumas A, Ricciardi W, Boccia S.

Eur J Public Health. 2016 Feb;26(1):168-75. doi: 10.1093/eurpub/ckv158. Epub 2015 Sep 14. Review.

PMID:
26370440
4.

Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.

Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR.

JAMA. 2003 Jan 15;289(3):313-22.

PMID:
12525232
5.

Cost-effectiveness of Lung Cancer Screening in Canada.

Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC, Evans WK.

JAMA Oncol. 2015 Sep;1(6):807-13. doi: 10.1001/jamaoncol.2015.2472.

PMID:
26226181
6.

Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.

Raymakers AJ, Mayo J, Lam S, FitzGerald JM, Whitehurst DG, Lynd LD.

Appl Health Econ Health Policy. 2016 Aug;14(4):409-18. doi: 10.1007/s40258-016-0226-5. Review.

PMID:
26873091
7.

Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.

Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.

Lung Cancer. 2005 May;48(2):171-85. Epub 2005 Jan 4.

PMID:
15829317
8.

Cost-effectiveness of CT screening in the National Lung Screening Trial.

Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, Gatsonis C; National Lung Screening Trial Research Team..

N Engl J Med. 2014 Nov 6;371(19):1793-802. doi: 10.1056/NEJMoa1312547.

9.

A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.

Villanti AC, Jiang Y, Abrams DB, Pyenson BS.

PLoS One. 2013 Aug 7;8(8):e71379. doi: 10.1371/journal.pone.0071379. Print 2013.

10.

Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.

Das P, Ng AK, Earle CC, Mauch PM, Kuntz KM.

Ann Oncol. 2006 May;17(5):785-93. Epub 2006 Feb 24.

PMID:
16500905
11.

Cost-effectiveness of the introduction of low-dose CT screening in Japanese smokers aged 55 to 74 years old.

Tabata H, Akita T, Matsuura A, Kaishima T, Matsuoka T, Ohisa M, Awai K, Tanaka J.

Hiroshima J Med Sci. 2014 Sep;63(1-3):13-22.

PMID:
25735063
12.

Cost-effectiveness of computed tomography screening for lung cancer in the United States.

McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS.

J Thorac Oncol. 2011 Nov;6(11):1841-8. doi: 10.1097/JTO.0b013e31822e59b3.

13.

The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening.

Wisnivesky JP, Mushlin AI, Sicherman N, Henschke C.

Chest. 2003 Aug;124(2):614-21.

PMID:
12907551
14.

Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.

Cressman S, Lam S, Tammemagi MC, Evans WK, Leighl NB, Regier DA, Bolbocean C, Shepherd FA, Tsao MS, Manos D, Liu G, Atkar-Khattra S, Cromwell I, Johnston MR, Mayo JR, McWilliams A, Couture C, English JC, Goffin J, Hwang DM, Puksa S, Roberts H, Tremblay A, MacEachern P, Burrowes P, Bhatia R, Finley RJ, Goss GD, Nicholas G, Seely JM, Sekhon HS, Yee J, Amjadi K, Cutz JC, Ionescu DN, Yasufuku K, Martel S, Soghrati K, Sin DD, Tan WC, Urbanski S, Xu Z, Peacock SJ; Pan-Canadian Early Detection of Lung Cancer Study Team..

J Thorac Oncol. 2014 Oct;9(10):1449-58. doi: 10.1097/JTO.0000000000000283.

15.

Overdiagnosis in low-dose computed tomography screening for lung cancer.

Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammem├Ągi MC, Chiles C, Black WC, Aberle DR; NLST Overdiagnosis Manuscript Writing Team..

JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738. Erratum in: JAMA Intern Med. 2014 May;174(5):828.

16.

Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.

Goulart BH, Ramsey SD.

Oncologist. 2013;18(8):941-6. doi: 10.1634/theoncologist.2013-0007. Epub 2013 Jul 19.

17.

Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.

Gould MK, Sanders GD, Barnett PG, Rydzak CE, Maclean CC, McClellan MB, Owens DK.

Ann Intern Med. 2003 May 6;138(9):724-35.

PMID:
12729427
18.

Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.

Goulart BH, Bensink ME, Mummy DG, Ramsey SD.

J Natl Compr Canc Netw. 2012 Feb;10(2):267-75. Review.

PMID:
22308519
19.

Screening for lung cancer with CT: a preliminary cost-effectiveness analysis.

Chirikos TN, Hazelton T, Tockman M, Clark R.

Chest. 2002 May;121(5):1507-14.

PMID:
12006436
20.

Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.

Black WC.

J Thorac Imaging. 2015 Mar;30(2):79-87. doi: 10.1097/RTI.0000000000000136. Review. Erratum in: J Thorac Imaging. 2015 Sep;30(5):W59.

Supplemental Content

Support Center